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The effects of a 7 d high-fructose diet (HFrD) or control diet on lipid metabolism were studied in a group of six healthy lean males. Plasma NEFA
and b-hydroxybutyrate concentrations, net lipid oxidation (indirect calorimetry) and exogenous lipid oxidation (13CO2 production) were monitored
in basal conditions, after lipid loading (olive oil labelled with [13C]triolein) and during a standardised mental stress. Lactate clearance and the
metabolic effects of an exogenous lactate infusion were also monitored. The HFrD lowered plasma concentrations of NEFA and b-hydroxybuty-
rate as well as lipid oxidation in both basal and after lipid-loading conditions. In addition, the HFrD blunted the increase in plasma NEFA and
exogenous lipid oxidation during mental stress. The HFrD also increased basal lactate concentrations by 31·8 %, and lactate production by
53·8 %, while lactate clearance remained unchanged. Lactate infusion lowered plasma NEFA with the control diet, and net lipid oxidation with
both the HFrD and control diet. These results indicate that a 7 d HFrD markedly inhibits lipolysis and lipid oxidation. The HFrD also increases
lactate production, and the ensuing increased lactate utilisation may contribute to suppress lipid oxidation.
High-fructose diets: Lipid metabolism: Lactate kinetics
Consumption of fructose-containing sweetened beverages has
increased markedly over the past decades, and is thought to
play a significant role in the current epidemics of obesity
and metabolic disorders(1,2). In rodents, high-sucrose or -fruc-
tose diets cause obesity, insulin resistance, diabetes mellitus,
dyslipidaemia and high blood pressure(3), while in humans,
high-fructose hyperenergetic diets (HFrD) lead, over a few
days, to the development of hypertriacylglycerolaemia and
hepatic insulin resistance(4 – 8). The metabolic effects of fruc-
tose have been widely studied, as reported in several recent
reviews(9,10); however, the mechanisms leading to fructose-
induced insulin resistance remain poorly understood.
Several observations indicate that diet-induced insulin resis-
tance bears strong relationships with disturbances of intracellu-
lar lipid metabolism(11). An impaired capacity to oxidise lipids
in skeletal muscle, and possibly in other tissues, is present in
insulin-resistant individuals(12,13). Impaired fat oxidation may
in turn lead to the accumulation of so-called ‘ectopic’ lipids,
i.e. intracellular storage of TAG in non-adipose tissue cells,
and of lipid metabolites, which may interfere with insulin signal-
ling and its actions(14). It can therefore be suspected that inhi-
bition of lipid oxidation may participate in the adverse
metabolic effects of high-fructose diets. To evaluate this hypoth-
esis, we studied the effects of a 6–7 d HFrD on lipid metabolism,
in a group of healthy young males. Whole-body net fat oxi-
dation, exogenous fat oxidation, adipose tissue lipolysis and
plasma ketone body release were challenged by a lipid load
that was followed by a mental stress, which stimulates sympath-
etic activity(15). All parameters were measured under fasting
conditions, after lipid loading and after mental stress. Since an
HFrD also causes a substantial rise in plasma lactate concen-
trations(6), and increased lactate utilisation may in turn affect
lipid metabolism(16 – 18), we also studied lactate kinetics with
[13C3]lactate infusion in the same subjects.
Methods
Subjects
Six healthy young males (age 24·7 (SD 3·1) years; weight 78·3
(SD 7·4) kg; BMI 23·1 (SD 2·2) kg/m2) were recruited into the
study. All were in good health, had no family history of type 2
diabetes mellitus and were non-smokers. None took any medi-
cation at the time of inclusion or during the study. The experi-
mental protocol was approved by the ethical board of
Lausanne University School of Biology and Medicine, and
every subject provided informed, written consent.
Dietary intervention
Each subject was randomised to one of two diets: (1) a 7 d
control diet calculated to provide his predicted energy
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requirements(19) multiplied by a factor of 1·5 to account for
the thermic effect of food and sedentary activity that was com-
posed of 55 % carbohydrate, 30 % fat and 15 % protein or (2)
the same diet supplemented with 3·0 g fructose/kg body
weight per d, corresponding to the fructose content of about
4 litres sweetened beverage. This resulted in a mean extra
fructose intake of 234 g and an excess energy intake of
about 3640 kJ/d, resulting in an overall diet providing 67 %
carbohydrate, 22 % fat and 11 % protein. The study was per-
formed on an out-patient basis, and fructose was provided as
packs of fructose monohydrate to be dissolved in water and
to be drunk in three divided doses with each main meal. A
3–5-week wash-out period separated the two diets. We have
observed in previous studies that a wash-out period of this dur-
ation is sufficient for complete return of metabolic parameters
to baseline(6,7).
Metabolic study 1: lactate infusion
On the morning of day 6 of each diet, subjects reported to the
metabolic investigation unit at 07.00 hours after an overnight
fast. Upon arrival they were requested to void, after which
their body weight was recorded. The subject was then comfor-
tably installed in a bed in a reclining position where they
remained quietly watching television for the next 6 h. Two
venous catheters were inserted, one into a forearm vein for
infusion of [6,6-2H2]glucose (2 mg/kg bolus followed by
20mg/kg per min between time 2120 to time 180 min) and
exogenous lactate (0·5 M-sodium lactate labelled with 0·05 %
[13C3]lactate, infused at a rate of 20 mmol/kg per min between
time 0 and 180 min), and the other into a wrist vein of
the contralateral arm for blood collections. The hand on this
side was maintained inside a thermostabilised box heated
at 508C to achieve arterialisation of venous blood. Respiratory
gas exchange was measured continuously using a ventilated
hood, open-circuit indirect calorimetry (Deltatrac II; Datex
Instruments, Helsinki, Finland). Blood collections were
obtained at time 2120 and every 30 min between 230 and
180 min for hormone and substrate measurements and for
the determination of plasma [6,6-2H2]glucose enrichment.
End-expiratory breath samples were collected every 30 min
in vacutainers for determination of 13CO2 enrichment.
A timed urine collection was taken during the experiment to
determine urea N excretion rate.
Metabolic study 2: lipid loading and mental stress
The present study took place on day 8 of each diet, and instru-
mentation procedures were the same as described for study 1.
After 120 min of fasting measurements, three oral loads of
10 g olive oil labelled with 100 mg [1-13C3]triolein (Cam-
bridge Isotope Laboratory, Cambridge, MA, USA) were
ingested at times 0, 60 and 120 min to measure exogenous
fat oxidation(20). A mental stress procedure, consisting of
5 min periods of complex mental arithmetic alternated with
5 min periods of Stroop’s word colour conflict tests(15),
was applied between 180 and 210 min. This procedure is
known to activate the sympatho-adrenal axis and to produce
stimulation of lipolysis(21,22). Blood collections were obtained
at 2120 min and every 30 min from 230 to 180 min,
and subsequently at 190, 200, 210 and 240 min for hormone
and substrate measurements and for determination of plasma
[6,6-2H2]glucose enrichment. Saliva samples were obtained
in basal conditions, after lipid loading and every 10 min
during the 30 min mental stress test by using a saliva collec-
tion kit (Sarstedt AG, Sevelen, Switzerland). Expiratory
breath samples were collected every 30 min in vacutainers
for determination of 13CO2 enrichment.
A timed urine collection was performed during the experi-
ment to determine urea N excretion.
Analytical procedures
Plasma glucose was measured with the glucose oxidase
method, using a Beckman Glucose Analyzer II (Beckman
Instruments, Palo Alto, CA, USA). Plasma insulin and salivary
cortisol concentrations were measured using RIA kits (Bio-
data, Guidoni, Montecello, Italy and DPC Inc., Los Angeles,
CA, USA, respectively). Plasma NEFA were measured color-
imetrically using a kit from Wako (Freiburg, Germany).
Plasma b-hydroxybutyrate and TAG were measured enzymi-
cally using a kit from Boehringer (Mannheim, Germany).
Plasma adrenaline and noradrenaline were measured by
HPLC(23). Plasma [6,6-2H2]glucose isotopic enrichment was
measured with GC-MS, as described previously(24,25). Breath
13CO2 isotopic enrichment was measured by isotope ratio
MS on a Tracermass C/N (SerCon Ltd, Crewe, Cheshire, UK).
Calculations
All calculation procedures have been reported in detail else-
where. The rates of glucose appearance and disappearance
were calculated from plasma [6,6-2H2]glucose isotopic enrich-
ment using Steele’s equations for steady-state conditions(26).
Exogenous oleate(20) and lactate(27) oxidations were calculated
from 13CO2 production. Whole-body net substrate oxidation
rates were calculated using the equations of Livesey &
Elia(28). During lactate infusion, it was assumed that lactate
disappearance was equal to net lactate oxidation in order to
calculate net glucose and lipid oxidation(27,29). This net lactate
oxidation may include oxidation of glucose synthesised from
lactate. Lactate clearance was calculated using a ‘pharmacoki-
netic’ model from changes in plasma lactate concentrations
during exogenous lactate infusion, and basal lactate pro-
duction was calculated as basal lactate concentration/lactate
clearance(30).
Statistical analysis
All results in the text and tables are expressed as mean values
with their standard errors. Comparisons between the control
diet and the HFrD, or between fasting conditions, post-lipid
conditions, and mental stress were done with the Wilcoxon
signed rank test.
Results
Lipid metabolism in basal and after lipid-loading conditions is
presented in Table 1 and illustrated in Fig. 1.
In basal conditions, the HFrD, compared with the control
diet, decreased plasma NEFA by 19·5 %, plasma b-hydroxy-
butyrate by 78·2 % and whole-body lipid oxidation by
A. Abdel-Sayed et al.394
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21·3 % (all P,0·05; Table 1). After lipid loading, there was
no significant change in plasma glucose, insulin or NEFA con-
centrations in either condition but plasma b-hydroxybutyrate
increased (P,0·05) in both conditions, although it tended to
be lower with the HFrD (P¼0·12; Fig. 1). Whole-body net
lipid oxidation increased slightly by 0·18 mg/kg per min
with the control diet and by 0·24 mg/kg per min with the
HFrD (NS). Absolute levels of lipid oxidation remained
lower (P,0·05) on the HFrD than with the control diet
(Table 1). Breath 13CO2 isotopic enrichment and oxidation
of exogenous lipids (Table 1) over the first 3 h after lipid load-
ing were comparable between the HFrD and control diet.
Lipid metabolism during mental stress
During mental stress, plasma cortisol, adrenaline and nor-
adrenaline concentrations increased to the same extent with
the HFrD and with the control diet (Table 2), while glucose
and insulin concentrations remained unchanged (Fig. 1).
Plasma NEFA increased significantly during mental stress,
but the integrated incremental area under the curve was sig-
nificantly lower with the HFrD (P,0·03) than with the control
diet (Fig. 1). The concentration of b-hydroxybutyrate did not
change during mental stress, and tended to be lower with the
HFrD than with the control diet (P¼0·12; Fig. 1). During the
Table 1. Effects of a high-fructose diet (HFrD) on lipid and energy metabolism in basal conditions and after lipid loading*
(Mean values with their standard errors)
Control HFrD
Basal Lipid loading Basal Lipid loading
Mean SEM Mean SEM Mean SEM Mean SEM
Plasma glucose (mmol/l) 4·6 0·1 4·3 0·2 4·5 0·1 4·5 0·1
Plasma NEFA (mmol/l) 0·41 0·09 0·45 0·05 0·33† 0·08 0·41 0·06
Plasma TAG (mmol/l) 0·49 0·05 0·67 0·11 0·81† 0·18 1·00† 0·20
Plasma b-hydroxybutyrate (mmol/l) 55 17 13† 3
Energy expenditure (kJ/kg per min) 0·057 0·005 0·057 0·004 0·057 0·005 0·057 0·005
Carbohydrate oxidation (mg/kg per min) 1·24 0·19 0·92 0·14 1·99† 0·19 1·62† 0·17
Lipid oxidation (mg/kg per min) 0·71 0·11 0·89 0·10 0·49† 0·10 0·73† 0·05
Exogenous lipid oxidation 27 3 24 1
* Basal conditions: blood samples were obtained in the fasting state, with a rest period of 120 min after instrumentation of the subject. Lipid loading:
blood samples were collected 150 and 180 min after lipid loading, and the values obtained were averaged for presentation.
† Mean value was significantly different from that of control (P,0·05).
Fig. 1. Changes in (A) plasma glucose, (B) insulin, (C) NEFA and (D) b-hydroxybutyrate concentrations during lipid loading and during mental stress (MS). Values
are means, with standard errors represented by vertical bars. (W), High-fructose diet; (V), control conditions; # , times at which olive oil was ingested. * Mean
values were significantly different (P,0·05).
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60 min period between 180 and 240 min, which corresponded
to the 30 min mental stress þ 30 min recovery, breath 13CO2
and exogenous lipid oxidation increased with both the HFrD
and control diet, but were significantly lower after the HFrD
(P,0·05; Table 1).
Lactate metabolism
Basal lactate production increased by 52·4 % while on the
HFrD (P,0·001). At the end of the dietary periods basal lac-
tate concentrations were 33·2 % higher with the HFrD than
with the control diet (P,0·01) (Table 3 and Fig. 2), but the
increment in plasma lactate (Fig. 2), and hence calculated lac-
tate clearance (Table 3), were comparable between the two
conditions. Calculated basal lactate production was signifi-
cantly higher while on the HFrD.
Exogenous lactate infusion did not change glucose rate of
appearance or plasma glucose concentrations (Table 3).
Plasma NEFA tended to be decreased (215 %; P¼0·12)
after the control diet, but not after the HFrD (Fig. 2 and
Table 3). Lactate infusion decreased net whole-body lipid oxi-
dation by 30·7 % with the control diet (P,0·02) and 34·1 %
with the HFrD (P,0·01; Table 3). Breath 13CO2 isotopic
enrichment increased similarly after the HFrD and control
diet and exogenous lactate oxidation was similar under both
conditions (8·0 (SEM 0·4) mmol/kg per min after the control
diet v. 8·7 (SEM 0·5) mmol/kg per min after the HFrD; NS).
Discussion
The present results demonstrate than a 7 d HFrD has important
effects on lipid metabolism and oxidation in healthy human
subjects and caused a significant (P,0·05) increase in fasting
plasma TAG concentrations(4,6,7,31). Although compliance to
fructose supplementation was not directly assessed, the con-
sistency of this observation with previous reports(4,6,7,9,31)
Table 2. Effects of a high-fructose diet (HFrD) on lipid and energy metabolism during mental stress
(Mean values with their standard errors)
Control HFrD
Mean SEM Mean SEM
Baseline*
Glucose (mmol/l) 4·3 0·2 4·7 0·2
NEFA (mmol/l) 0·41 0·06 0·46 0·05
Adrenaline (pg/ml) 47 7 46 13
Noradrenaline (pg/ml) 130 55 135 65
Salivary cortisol (nmol/l) 4·1 0·4 4·6 0·2
Incremental areas under the curve
after mental stress
Glucose (mmol/l £ 30 min) 16 25 29 8
NEFA (mmol/l £ 30 min) 8·0 2·2 3·8† 2·4
Adrenaline (pg/ml £ 30 min) 689 235 620 346
Noradrenaline (pg/ml £ 30 min) 2783 562 2746 850
Salivary cortisol (nmol/l £ 30 min) 11·4 5·3 32 23
Exogenous lipid oxidation after mental
stress (mg/kg per h)
15 2 11† 2
* Basal conditions: blood samples were obtained immediately before mental stress, i.e. 180 min after the beginning of the lipid loading.
† Mean value was significantly different from that of control (P,0·05).
Table 3. Effects of a high-fructose diet (HFrD) on energy and substrate metabolism in basal conditions and after lactate infusion
(Mean values with their standard errors)
Control HFrD
Basal Lactate Basal Lactate
Mean SEM Mean SEM Mean SEM Mean SEM
Plasma glucose (mmol/l) 4·8 0·1 4·9 0·1 5·1 0·2 5·0 0·2
Plasma NEFA (mmol/l) 0·60 0·07 0·52 0·04 0·36* 0·09 0·39* 0·09
Plasma lactate (mmol/l) 0·85 0·05 2·50† 0·09 1·12 0·17 2·75† 0·14
Lactate clearance (ml/min) 12 1 13 2
Lactate production (mmol/kg per min) 10·4 1·2 16·0* 5·3
Glucose rate of appearance (mmol/kg per min) 11·5 0·5 10·4 0·5 11·8 0·5 10·3 0·5
Energy expenditure (kJ/kg per min) 0·057 0·005 0·062 0·005 0·054 0·005 0·057 0·004
Carbohydrate oxidation (mg/kg per min) 1·36 0·11 0·65† 0·19 1·95* 0·24 0·85*† 0·25
Lipid oxidation (mg/min) 0·65 0·06 0·45† 0·11 0·41* 0·07 0·27*† 0·09
Lactate oxidation (mmol/kg per min) 0 0 20 0 0 0 20 0
* Mean value was significantly different from that of control (P,0·05).
† Mean value was significantly different from that in basal conditions (P,0·05).
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provides indirect evidence that the bulk of the supplementary
fructose prescribed to the participants was indeed consumed.
Besides this well-known increase in plasma TAG concen-
trations, the HFrD significantly inhibited several pathways of
lipid catabolism. In basal conditions, the HFrD significantly
decreased plasma NEFA concentrations, net lipid oxidation
and plasma b-hydroxybutyrate concentrations. After lipid
loading, the increase in net lipid oxidation and exogenous
lipid oxidation were comparable after the HFrD and control
diet, but mental stress markedly blunted the stimulation of
plasma NEFA and b-hydroxybutyrate release. Whole-body
net lipid oxidation could not be calculated during mental
stress, because the significant degree of hyperventilation
which occurs during this procedure precludes the accurate
calculation of the RER(15). Exogenous lipid oxidation
could, however, still be calculated since this procedure is
less sensitive to small inaccuracies in the measurement of
CO2 production
(32), and was also significantly inhibited after
the HFrD.
The lower basal plasma NEFA concentrations, and the
blunted response of NEFA to mental stress, indicate an inhi-
bition of adipose tissue lipolysis after the HFrD. Under such
conditions, HFrD-induced hypertriacylglycerolaemia is unli-
kely to be secondary to an increased hepatic re-esterification,
and is likely to be related to fructose-induced stimulation of
hepatic de novo lipogenesis. However, the inhibition of lipoly-
sis may in turn be directly responsible for lower whole-body
net lipid oxidation and plasma b-hydroxybutyrate concen-
trations, since NEFA concentrations are the main determinant
of these processes. Alternatively, a direct inhibition of hepatic
b-oxidation and ketogenesis may also be involved. Rats
prone to develop diet-induced obesity exhibit similar altera-
tions to those observed in human subjects after the HFrD,
i.e. decreased basal whole-body and hepatic lipid oxidation
and blunted stimulation of ketone body release. These effects
were associated with decreased hepatic expression of genes
involved in lipid transport and oxidation(33). Fructose, by
exerting a direct effect on liver metabolism, is likely to act
on similar pathways. In support of this hypothesis, it has
been reported that an HFrD, but not a high-glucose diet, mark-
edly reduces hepatic b-oxidation in rats through inhibition of
the expression of PPARa-dependent genes(34).
Intriguingly, these effects of the HFrD on lipid metabolism
were observed in the absence of significant changes in
plasma insulin, and with only minimal changes in plasma glu-
cose, suggesting that a change in insulin secretion is not pri-
marily involved. The HFrD therefore lowered plasma NEFA
presumably through inhibition of lipolysis. The mediator(s)
responsible for this effect remain speculative at this point.
Changes in plasma concentrations of key metabolic substrates
appear to be prime candidates. As already reported in several
studies(35,36), an HFrD increases basal lactate concentrations.
Our present results, collected during an exogenous lactate
infusion, indicate that lactate clearance was essentially
unchanged after the HFrD, and hence the observed increase
in lactate concentration can be attributed to an increased lac-
tate production. The results of the present experiment do not
allow us to identify the sites of lactate production. The
increased lactate production was matched by increased lactate
utilisation at the whole-body level, and it is reasonable to
assume that part of it was oxidised in adipose tissue and skel-
etal muscle. We further propose the hypothesis that increased
muscle lactate uptake partially replaced lipid as an energy sub-
strate and hence contributed to inhibit lipid oxidation.
Our observation of suppressed whole-body net lipid
oxidation after lactate infusion is certainly consistent with
Fig. 2. Changes in (A) plasma glucose, (B) insulin, (C) NEFA and (D) lactate concentrations during exogenous lactate infusion. Values are means, with standard
errors represented by vertical bars. (W), High-fructose diet; (V), control conditions. * Mean values were significantly different (P,0·05).
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this hypothesis. Furthermore, we propose that increased lactate
metabolism in adipose tissue may contribute to the inhibition
of adipose tissue lipolysis. In support of this hypothesis,
exogenous lactate infusion significantly lowered plasma
NEFA in subjects fed the control diet. Lactate infusion, how-
ever, failed to further suppress plasma NEFA after the HFrD,
possibly because increased adipose lactate metabolism was
already maximally effective under such conditions.
The present study has several limitations that have to be
acknowledged. First, compliance to the diet and fructose
supplementation could not be directly assessed; however, the
HFrD did cause the expected increase in plasma TAG concen-
trations, which indicates that the bulk of the fructose sup-
plement had been ingested as prescribed. It remains,
however, possible that fructose supplementation led to
changes in fat, protein and non-fructose carbohydrate intake.
Second, the HFrD provided excess fructose, total carbohydrate
and energy intake. Although it is possible to speculate, based
on previous reports showing an acute suppression of NEFA
and a marked increase in lactate concentrations after fructose
ingestion(35 – 37), that the observed inhibition of plasma NEFA
was essentially linked to fructose intake, one cannot exclude
that similar effects would be produced by glucose or fat over-
feeding as well. Third, the volunteers of the present study
were submitted to supplementation with a large fructose
load, which largely exceeds usual fructose intake(38,39). Such
high sugar intakes may, however, be occasionally encountered
in clinical practice. The present data nonetheless indicate that
a very high fructose intake causes significant changes in adi-
pose tissue lipolysis, and hence that fructose intake is likely
to modulate the functions of adipocytes. Our previous obser-
vation, that overfeeding with half the dose of fructose as
used in the present study led to a significant decrease in fasting
plasma NEFA concentrations(7), suggests that such an
effect may also be present with lower, more usual fructose
intake. Fourth, the 7 d HFrD failed to induce a significant
whole-body insulin resistance in these healthy volunteers, as
previously reported(6,7). This contrasts with animal studies
showing that an HFrD leads to an important reduction of insu-
lin sensitivity, or even to overt diabetes mellitus (for a review,
see Bizeau & Pagliassotti(40)). Higher fructose intakes in
animal studies may explain part of these differences. The dur-
ation of fructose overfeeding may also be a crucial factor,
since insulin resistance was observed after several weeks of
an HFrD in rodents. And finally, the calculation of exogenous
lipid oxidation rests on the measurements of breath 13CO2,
which increases with an important lag time. After lipid load-
ing, the breath 13CO2 curve obtained after the HFrD and
after the control diet started to dissociate during hour 3 of
lipid loading, but the difference became significant only
during hour 4, i.e. during mental stress. We cannot, however,
unequivocally attribute this difference to fructose-induced
alterations of the metabolic responses to stress, since it may
merely represent a carry-over effect of lipid loading. This
difference nonetheless indicates that the HFrD significantly
inhibited exogenous lipid oxidation, be it lower utilisation of
exogenous lipids or impaired stimulation by mental stress.
In summary, the present results indicate that, in healthy
human subjects, a 7 d supplementation with a large amount
of fructose decreases whole-body lipid oxidation and hepatic
ketogenesis. These effects, if present with lower, more
usual, fructose intakes, may, in the long term, play an import-
ant role in the development of fructose-induced metabolic dis-
orders. It has indeed been reported, in an animal model, that
fructose-induced inhibition of hepatic lipid oxidation was
directly linked to hepatic fat accumulation and hypertriacyl-
glycerolaemia(34). An HFrD also stimulates lactate production,
and the ensuing increase in extrahepatic lactate metabolism
may contribute to impair lipid mobilisation and oxidation.
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